Problemi speciali
Il deficit di glucosio-6-fosfato deidrogenasi
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Matteo Bramuzzo1, Sara Lega1, Irene Bruno2
1Scuola di Specializzazione in Pediatria, Università di Trieste
2Malattie Metaboliche e Rare, Clinica Pediatrica, IRCCS Pediatrico “Burlo Garofolo”, Trieste
Dicembre 2011 - pagg. 648 -652
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked inherited disorder and it is the most common enzymatic defect in the world. G6PD is an enzyme involved in the genesis of NADPH which preserves the cells from oxidative stress. G6PD deficiency is usually asymptomatic but can become clinically apparent as haemolytic crisis triggered by the ingestion of oxidative agents (foods or drugs) or infections. Neonatal jaundice or chronic non-spherocytic haemolytic anaemia may be other manifestations of the disease. The most effective management of G6PD deficiency is to prevent haemolysis by avoiding oxidative stress; blood transfusions may be required in case of severe haemolysis. Screening programmes are helpful in identifying susceptible patients and so in preventing severe haemolytic crisis.
Parole chiave
Classificazione MeSH
Bibliografia
1. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician 2005;72: 1277-82.
2. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371:64-74.
3. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med 1998;76:581-8.
4. Pietrapertosa A, Palma A, Campanale D, Delios G, Vitucci A, Tannoia N. Genotype and phenotype correlation in glucose-6-phosphate dehydrogenase deficiency. Haematologica 2001;86:30-5.
5. Beutler E. G6PD deficiency. Blood 1994; 84:3613-36.
6. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells Mol Dis 2009;42:267-78.
7. Miller J, Golenzer J, Spira DT, Kosower NS. Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes. Exp Parasitol 1984;57:239-47.
8. Cappadoro M, Giribaldi G, O’Brien E, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD) deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-34.
9. Atay E, Bozaykut A, Ipek IO. Glucose-6-phosphate dehydrogenase deficiency in neonatal in direct hyperbilirubinemia. J Trop Pediatr 2006;52:56-8.
10. Fiorelli G, Martinez di Montemuros F, Cappellini MD. Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants. Baillières Best Pract Res Clin Haematol 2000; 13:39-55.
11. Angle CR. Glucose-6-phosphate dehydrogenase deficiency and acute renal failure. Lancet 1972;2:134.
12. Schilirò G, Russo A, Curreri R, Marino S, Sciotto A, Russo G. Glucose-6-phosphate dehydrogenase deficiency in Sicily: incidence biochemical characteristics and clinical implications. Clin Genet 1979;15:183-8.
13. Fischer TM, Meloni T, Pescarmona GP, Arese P. Membrane cross-binding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysis. Br J Haematol 1985;59:159-69.
14. Beutler E. A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 1966;28:553-62.
15. Mason PJ. New insights into G6PD deficiency. Br J Haematol 1996;94:585-91.
16. Bain BJ. Diagnosis from the blood smear. N Engl J Med 2005;353:498-507.
17. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67:601-11.
18. Khneisser I, Adib SM, Loiselet J, Megarbane A. Cost-benefit analysis of G6PD screening in Lebanese newborn males. J Med Liban 2007;55:129-32.
19. Cohan N, Karimi M, Khalili AH, Falahzadeh MH, Samadi B, Mahdavi MR. The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern Iran. J Med Screen 2010;17:66-7.
20. Youngster I, Arcavi L, Schechmaster R, et al. Medications and glucose-6-phospate dehydrogenase deficiency. Drug Saf 2010;33:713-26.
21. Beutler E, Mathai CK, Smith JE. Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood 1968; 31:131-50.
Corrispondenza: bramuzzo@tiscalinet.it